
Advertising Standards Authority Bans Voy At-Home Test Kit Adverts for Misleading Low Testosterone Claims
The Advertising Standards Authority (ASA) has banned three adverts from online healthcare provider Voy, ruling they made unsubstantiated claims about symptoms of low testosterone and the efficacy of its at-home test kits. The ASA found the marketing materials encouraged consumers to link common, non-specific symptoms such as fatigue and low mood directly to low testosterone levels, implying their test could provide a definitive diagnosis.
Voy, which offers blood tests for various health markers, including testosterone, argued its adverts were informational and referenced publicly available data. However, the ASA concluded that the adverts' phrasing exaggerated the diagnostic capabilities of the test and suggested that a positive result could singularly explain a range of general ailments. This approach risked unduly alarming consumers and promoting unnecessary testing.
The ruling mandates that Voy must ensure future advertising clearly and accurately represents the purpose and diagnostic limitations of its at-home test kits. The company is prohibited from implying that its tests can provide a direct diagnosis for complex, multi-faceted symptoms without robust scientific evidence to support such claims. This decision reinforces regulatory scrutiny on direct-to-consumer health diagnostics.






